Waters Corporation elects Flemming Ornskov to Board of Directors

23-Jun-2017 - USA

Waters Corporation announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters^® Corporation effective today.

"It is an honor to welcome Flemming Ornskov to our Board of Directors," said Christopher J. O'Connell, Waters Corporation President and CEO. "Flemming's broad, global leadership experience in the biopharmaceutical industry will add great value to Waters' strategic and governance processes. Moreover, Flemming's strong character and passion for human health make him a great addition to Waters' values-oriented culture."

“I have been impressed with the Waters Corporation’s support for researchers and organizations whose innovative work helps heal, feed and protect people around the world,” said Shire’s Flemming Ornskov, M.D., M.P.H. “I look forward to working with Chris and the entire Board in pursuing a bright future for the Company, its employees and those they serve.”

Dr. Ornskov was appointed Chief Executive Officer of Shire plc in April, 2013, where he serves as Chairman of the Executive Committee, and is a member of the Board of Directors. Dr. Ornskov brings broad operational and medical knowledge, and extensive international, strategic and operational experience in the pharmaceutical sector. Prior to Shire, Dr. Ornskov held key executive leadership positions at Bayer, Bausch & Lomb, Inc., Merck & Co., Inc. and Novartis AG. Dr. Ornskov received his MD from the University of Copenhagen, his MBA from INSEAD, and his Master of Public Health from Harvard University. Before his business career, Dr. Ornskov, trained as an intern and resident in pediatrics at the University Hospital of Copenhagen.

https://www.chemeurope.com/en/news/163815/waters-corporation-elects-flemming-ornskov-to-board-of-directors.html